BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 35792988)

  • 21. Modification of cytokine-induced killer cells with folate receptor alpha (FRα)-specific chimeric antigen receptors enhances their antitumor immunity toward FRα-positive ovarian cancers.
    Zuo S; Wen Y; Panha H; Dai G; Wang L; Ren X; Fu K
    Mol Immunol; 2017 May; 85():293-304. PubMed ID: 28360017
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Phenotypic characterization and anti-tumor effects of cytokine-induced killer cells derived from cord blood.
    Zhang Z; Zhao X; Zhang T; Wang L; Yang L; Huang L; Li F; Liu J; Yue D; Wang F; Li J; Guan F; Xu Y; Zhang B; Zhang Y
    Cytotherapy; 2015 Jan; 17(1):86-97. PubMed ID: 25457278
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Influence of autologous dendritic cells on cytokine-induced killer cell proliferation, cell phenotype and antitumor activity
    Cao J; Chen C; Wang Y; Chen X; Chen Z; Luo X
    Oncol Lett; 2016 Sep; 12(3):2033-2037. PubMed ID: 27602134
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Influence of murine mesenchymal stem cells on proliferation, phenotype, vitality, and cytotoxicity of murine cytokine-induced killer cells in coculture.
    Bach M; Schimmelpfennig C; Stolzing A
    PLoS One; 2014; 9(2):e88115. PubMed ID: 24516591
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Arsenic trioxide inhibits lung metastasis of mouse colon cancer via reducing the infiltration of regulatory T cells.
    Wang L; Hu X; Xu Y; Liu Z
    Tumour Biol; 2016 Nov; 37(11):15165-15173. PubMed ID: 27677289
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Inducible costimulator (ICOS) enhances the cytolytic activity of cytokine-induced killer cells against gallbladder cancer in vitro and in vivo.
    Wang J; He M; Shi W; Sha H; Feng J; Wang S; Wang Y
    Cancer Invest; 2009 Mar; 27(3):244-50. PubMed ID: 19194830
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Phenotypic and functional characterization of cytokine-induced killer cells derived from preterm and term infant cord blood.
    Zhang Q; Wang L; Luo C; Shi Z; Cheng X; Zhang Z; Yang Y; Zhang Y
    Oncol Rep; 2014 Nov; 32(5):2244-52. PubMed ID: 25176036
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Clinical Trials with Combination of Cytokine-Induced Killer Cells and Dendritic Cells for Cancer Therapy.
    Garofano F; Gonzalez-Carmona MA; Skowasch D; Schmidt-Wolf R; Abramian A; Hauser S; Strassburg CP; Schmidt-Wolf IGH
    Int J Mol Sci; 2019 Sep; 20(17):. PubMed ID: 31484350
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A CTLA-4 blocking strategy based on Nanoboby in dendritic cell-stimulated cytokine-induced killer cells enhances their anti-tumor effects.
    Wang W; Wang X; Yang W; Zhong K; He N; Li X; Pang Y; Lu Z; Liu A; Lu X
    BMC Cancer; 2021 Sep; 21(1):1029. PubMed ID: 34525966
    [TBL] [Abstract][Full Text] [Related]  

  • 30. High Expression of Cannabinoid Receptor 2 on Cytokine-Induced Killer Cells and Multiple Myeloma Cells.
    Garofano F; Schmidt-Wolf IGH
    Int J Mol Sci; 2020 May; 21(11):. PubMed ID: 32471216
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Optimization of therapeutic T cell expansion in G-Rex device and applicability to large-scale production for clinical use.
    Gotti E; Tettamanti S; Zaninelli S; Cuofano C; Cattaneo I; Rotiroti MC; Cribioli S; Alzani R; Rambaldi A; Introna M; Golay J
    Cytotherapy; 2022 Mar; 24(3):334-343. PubMed ID: 35063359
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Implication of different effector mechanisms by cord blood-derived and peripheral blood-derived cytokine-induced killer cells to kill precursor B acute lymphoblastic leukemia cell lines.
    Durrieu L; Lemieux W; Dieng MM; Fontaine F; Duval M; Le Deist F; Haddad E
    Cytotherapy; 2014 Jun; 16(6):845-56. PubMed ID: 24529554
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A novel method to expand large numbers of CD56(+) natural killer cells from a minute fraction of selectively accessed cryopreserved cord blood for immunotherapy after transplantation.
    Vasu S; Berg M; Davidson-Moncada J; Tian X; Cullis H; Childs RW
    Cytotherapy; 2015 Nov; 17(11):1582-93. PubMed ID: 26432560
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Protective role of functionalized single walled carbon nanotubes enhance ex vivo expansion of hematopoietic stem and progenitor cells in human umbilical cord blood.
    Bari S; Chu PP; Lim A; Fan X; Gay FP; Bunte RM; Lim TK; Li S; Chiu GN; Hwang WY
    Nanomedicine; 2013 Nov; 9(8):1304-16. PubMed ID: 23732300
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Expansion of Philadelphia chromosome-negative CD3(+)CD56(+) cytotoxic cells from chronic myeloid leukemia patients: in vitro and in vivo efficacy in severe combined immunodeficiency disease mice.
    Hoyle C; Bangs CD; Chang P; Kamel O; Mehta B; Negrin RS
    Blood; 1998 Nov; 92(9):3318-27. PubMed ID: 9787169
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Dendritic Cell Immunotherapy Combined with Cytokine-Induced Killer Cells Effectively Suppresses Established Hepatocellular Carcinomas in Mice.
    Jung NC; Lee JH; Choi HJ; Hwang SU; Song JY; Seo HG; Choi J; Jung SY; Han SG; Lim DS
    Immunol Invest; 2016 Aug; 45(6):553-65. PubMed ID: 27410037
    [TBL] [Abstract][Full Text] [Related]  

  • 37. In vivo distribution and antitumor effect of infused immune cells in a gastric cancer model.
    Du X; Jin R; Ning N; Li L; Wang Q; Liang W; Liu J; Xu Y
    Oncol Rep; 2012 Nov; 28(5):1743-9. PubMed ID: 22948809
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Influence of dendritic cells on biological activity of the homologous CIK cells and its anti-leukemia effect in vitro.
    Wei XC; Zhai XH; Han XR; Yang DD; Wang QS
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2010 Aug; 18(4):946-51. PubMed ID: 20723306
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The therapeutic effect of cytokine-induced killer cells on pancreatic cancer enhanced by dendritic cells pulsed with K-ras mutant peptide.
    Tan G; Zhang X; Feng H; Luo H; Wang Z
    Clin Dev Immunol; 2011; 2011():649359. PubMed ID: 22347323
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Improving Clinical Manufacturing of IL-15 Activated Cytokine-Induced Killer (CIK) Cells.
    Bremm M; Pfeffermann LM; Cappel C; Katzki V; Erben S; Betz S; Quaiser A; Merker M; Bonig H; Schmidt M; Klingebiel T; Bader P; Huenecke S; Rettinger E
    Front Immunol; 2019; 10():1218. PubMed ID: 31214182
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.